OBJECTIVE: Growth hormone (GH) resistance leads to enhanced insulin sensitivity, decreased systolic blood pressure and increased lifespan. The aim of this study was to determine if there is a shift in the balance of the renin-angiotensin system (RAS) towards the ACE2/Ang-(1-7)/Mas receptor axis in the heart and the kidney of a model of GH resistance and retarded aging, the GH receptor knockout (GHR-/-) mouse. DESIGN: RAS components were evaluated in the heart and the kidney of GHR-/- and control mice by immunohistochemistry and Western blotting (n=12 for both groups). RESULTS: The immunostaining of Ang-(1-7) was increased in both the heart and the kidney of GHR-/- mice. These changes were concomitant with an increased immunostaining of the Mas receptor and ACE2 in both tissues. The immunostaining of AT1 receptor was reduced in heart and kidney of GHR-/- mice while that of AT2 receptor was increased in the heart and unaltered in the kidney. Ang II, ACE and angiotensinogen levels remained unaltered in the heart and the kidney of GH resistant mice. These results were confirmed by Western blotting and correlated with a significant increase in the abundance of the endothelial nitric oxide synthase in both tissues. CONCLUSIONS: The shift within the RAS towards an exacerbation of the ACE2/Ang-(1-7)/Mas receptor axis observed in GHR-/- mice could be related to a protective role in cardiac and renal function; and thus, possibly contribute to the decreased incidence of cardiovascular diseases displayed by this animal model of longevity.
OBJECTIVE:Growth hormone (GH) resistance leads to enhanced insulin sensitivity, decreased systolic blood pressure and increased lifespan. The aim of this study was to determine if there is a shift in the balance of the renin-angiotensin system (RAS) towards the ACE2/Ang-(1-7)/Mas receptor axis in the heart and the kidney of a model of GH resistance and retarded aging, the GH receptor knockout (GHR-/-)mouse. DESIGN: RAS components were evaluated in the heart and the kidney of GHR-/- and control mice by immunohistochemistry and Western blotting (n=12 for both groups). RESULTS: The immunostaining of Ang-(1-7) was increased in both the heart and the kidney of GHR-/- mice. These changes were concomitant with an increased immunostaining of the Mas receptor and ACE2 in both tissues. The immunostaining of AT1 receptor was reduced in heart and kidney of GHR-/- mice while that of AT2 receptor was increased in the heart and unaltered in the kidney. Ang II, ACE and angiotensinogen levels remained unaltered in the heart and the kidney of GH resistant mice. These results were confirmed by Western blotting and correlated with a significant increase in the abundance of the endothelial nitric oxide synthase in both tissues. CONCLUSIONS: The shift within the RAS towards an exacerbation of the ACE2/Ang-(1-7)/Mas receptor axis observed in GHR-/- mice could be related to a protective role in cardiac and renal function; and thus, possibly contribute to the decreased incidence of cardiovascular diseases displayed by this animal model of longevity.
Authors: Patricia E Gallagher; Mark C Chappell; Carlos M Ferrario; E Ann Tallant Journal: Am J Physiol Cell Physiol Date: 2005-09-21 Impact factor: 4.249
Authors: Emil Egecioglu; Mikael Bjursell; Anna Ljungberg; Suzanne L Dickson; John J Kopchick; Göran Bergström; Lennart Svensson; Jan Oscarsson; Jan Törnell; Mohammad Bohlooly-Y Journal: Am J Physiol Endocrinol Metab Date: 2005-09-20 Impact factor: 4.310
Authors: Robson A S Santos; Carlos H Castro; Elisandra Gava; Sérgio V B Pinheiro; Alvair P Almeida; Renata Dutra de Paula; Jader S Cruz; Anderson S Ramos; Kaleizu T Rosa; Maria C Irigoyen; Michael Bader; Natalia Alenina; Gregory T Kitten; Anderson J Ferreira Journal: Hypertension Date: 2006-03-27 Impact factor: 10.190
Authors: Jewell A Jessup; Patricia E Gallagher; David B Averill; K Bridget Brosnihan; E Ann Tallant; Mark C Chappell; Carlos M Ferrario Journal: Am J Physiol Heart Circ Physiol Date: 2006-06-09 Impact factor: 4.733
Authors: Gavin Y Oudit; Andrew M Herzenberg; Zamaneh Kassiri; Denise Wong; Heather Reich; Rama Khokha; Michael A Crackower; Peter H Backx; Josef M Penninger; James W Scholey Journal: Am J Pathol Date: 2006-06 Impact factor: 4.307
Authors: Marina C Muñoz; Valeria Burghi; Johanna G Miquet; Jorge F Giani; Ricardo D Banegas; Jorge E Toblli; Yimin Fang; Feiya Wang; Andrzej Bartke; Fernando P Dominici Journal: J Endocrinol Date: 2014-04-22 Impact factor: 4.286
Authors: Adam Jara; Chance M Benner; Don Sim; Xingbo Liu; Edward O List; Lara A Householder; Darlene E Berryman; John J Kopchick Journal: Endocrinology Date: 2013-01-01 Impact factor: 4.736
Authors: Soudeh Ghafouri-Fard; Rezvan Noroozi; Mir Davood Omrani; Wojciech Branicki; Ewelina Pośpiech; Arezou Sayad; Krzysztof Pyrc; Paweł P Łabaj; Reza Vafaee; Mohammad Taheri; Marek Sanak Journal: Vascul Pharmacol Date: 2020-05-11 Impact factor: 5.773
Authors: Larissa Pernomian; Mayara Santos Gomes; Carolina Baraldi Araujo Restini; Ana Maria de Oliveira Journal: Biomed Res Int Date: 2014-04-29 Impact factor: 3.411